LPAR2
Lysophosphatidic acid receptor 2
Also known as: EDG-4, EDG4, LPA2, LPAR2_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9HBW0
- Gene
- LPAR2
- Ensembl
- ENSG00000064547
- Chromosome
- 19
- Canonical length
- 348 aa
- Protein class
- G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters
OverviewNCBI Gene
This gene encodes a member of family I of the G protein-coupled receptors, as well as the EDG family of proteins. This protein functions as a lysophosphatidic acid (LPA) receptor and contributes to Ca2+ mobilization, a critical cellular response to LPA in cells, through association with Gi and Gq proteins. An alternative splice variant has been described but its full length sequence has not been determined. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
348 residues, UniProt reviewed canonical sequence.
>Q9HBW0|LPAR2
1 MGQCYYNETI GFFYNNSGKE LSSHWRPKDV VVVALGLTVS VLVLLTNLLV IAAIASNRRF
61 HQPIYYLLGN LAAADLFAGV AYLFLMFHTG PRTARLSLEG WFLRQGLLDT SLTASVATLL
121 AIAVERHRSV MAVQLHSRLP RGRVVMLIVG VWVAALGLGL LPAHSWHCLC ALDRCSRMAP
181 LLSRSYLAVW ALSSLLVFLL MVAVYTRIFF YVRRRVQRMA EHVSCHPRYR ETTLSLVKTV
241 VIILGAFVVC WTPGQVVLLL DGLGCESCNV LAVEKYFLLL AEANSLVNAA VYSCRDAEMR
301 RTFRRLLCCA CLRQSTRESV HYTSSAQGGA STRIMLPENG HPLMDSTLLocalizationUniProt · AlphaFold · HPA
Whether an antibody against LPAR2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 7
- Mean surface accessibility (rSASA)
- 0.31
- Highest tissue expression
- 74 nTPM
Expression across tissuesHPA
Tissue
- spleen: 74 nTPM
- bone marrow: 49 nTPM
- testis: 49 nTPM
- stomach: 32 nTPM
- lung: 28 nTPM
- pancreas: 27 nTPM
Single-cell type
- neutrophils: 159 nCPM
- neutrophil progenitors: 39 nCPM
- sertoli cells: 38 nCPM
- foveolar cells: 27 nCPM
- mucous neck cells: 26 nCPM
- esophageal apical cells: 24 nCPM
Immune cell
- T-reg: 26 nTPM
- memory CD4 T-cell: 21 nTPM
- naive CD4 T-cell: 18 nTPM
- MAIT T-cell: 16 nTPM
- naive CD8 T-cell: 14 nTPM
- memory CD8 T-cell: 12 nTPM
Brain region
- hypothalamus: 13 nTPM
- cerebral cortex: 12 nTPM
- white matter: 10 nTPM
- medulla oblongata: 9.8 nTPM
- pons: 9.7 nTPM
- choroid plexus: 9.1 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.87
- gnomAD pLI
- 0.04
- gnomAD missense Z
- 1.85
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 6% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- adenylate cyclase-activating G protein-coupled receptor signaling pathway
- G protein-coupled receptor signaling pathway
- positive regulation of cytosolic calcium ion concentration
- positive regulation of MAPK cascade
- positive regulation of Rho protein signal transduction
Molecular functions
- G protein-coupled receptor activity
- lipid binding
- lysophosphatidic acid receptor activity
- PDZ domain binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
- G protein-coupled receptor, rhodopsin-like
- Lysophosphatidic acid receptor
- GPCR, rhodopsin-like, 7TM
- 7 transmembrane receptor (rhodopsin family)
- Lysophosphatidic acid receptor EDG-4
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of LPAR2 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads LPAR2 as an antibody target. Whether an autoantibody or antibody against LPAR2 could matter depends on whether native LPAR2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
LPAR2 is annotated at the cell surface, where native LPAR2 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label LPAR2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...